Top compounds associated with response to KRAS


Feature Type Standardized
Nominal ANOVA
mRNA AT13387 CTRPv2 pan-cancer AAC 0.00037 1
mRNA Irinotecan FIMM pan-cancer AAC -0.00078 1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -6.2e-05 1
mRNA AICAR GDSC1000 pan-cancer AAC -4.6e-05 1
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 8.4e-05 1
mRNA decitabine CTRPv2 pan-cancer AAC -2.9e-05 1
Download CSV